292966625	292966625	CD	B-NP	O
|	|	NN	I-NP	O
AUMC	AUMC	NN	I-NP	O
|	|	NN	I-NP	O
92601581	92601581	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
2623004	2623004	CD	B-NP	O
|	|	CC	I-NP	O
11/10/2007	11/10/2007	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Unsigned	Unsigned	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
8/5/2007	8/5/2007	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Unsigned	Unsigned	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/18/2007	1/18/2007	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
NUSBAUM	NUSBAUM	NNP	B-NP	O
,	,	,	O	O
WILLY	WILLY	NNP	B-NP	O
M.D.	M.D.	NNP	I-NP	O
SERVICE	SERVICE	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Renal	Renal	NNP	I-NP	O
Service	Service	NNP	I-NP	O
.	.	.	O	O

PRINCIPAL	PRINCIPAL	JJ	B-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Fungemia	Fungemia	NN	B-NP	O
.	.	.	O	O

LIST	LIST	NN	B-NP	O
OF	OF	IN	B-PP	O
OTHER	OTHER	NNP	B-NP	O
PROBLEMS	PROBLEMS	NNP	I-NP	O
AND	AND	CC	O	O
DIAGNOSES	DIAGNOSES	NNP	B-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

End-stage	End-stage	JJ	B-NP	O
renal	renal	JJ	I-NP	O
disease	disease	NN	I-NP	O
on	on	IN	B-PP	O
dialysis	dialysis	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Diabetes	Diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Hyperlipidemia	Hyperlipidemia	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

MRSA	MRSA	NN	B-NP	O
osteomyelitis	osteomyelitis	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

AV	AV	NN	B-NP	O
graft	graft	NN	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Spinal	Spinal	JJ	B-NP	O
stenosis	stenosis	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Paroxysmal	Paroxysmal	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

CVA	CVA	NN	B-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Depression	Depression	NN	B-NP	O
.	.	.	O	O

BRIEF	BRIEF	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
59-year-old	59-year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
morbid	morbid	NN	B-NP	O
obesity	obesity	NN	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
end-stage	end-stage	JJ	B-NP	O
renal	renal	JJ	I-NP	O
disease	disease	NN	I-NP	O
on	on	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
hyperlipidemia	hyperlipidemia	NN	B-NP	O
,	,	,	O	O
MRSA	MRSA	NN	B-NP	O
osteomyelitis	osteomyelitis	NN	I-NP	O
s/p	s/p	NN	I-NP	O
spinal	spinal	JJ	I-NP	O
fusion	fusion	NN	I-NP	O
and	and	CC	I-NP	O
cord	cord	NN	I-NP	O
compression	compression	NN	I-NP	O
,	,	,	O	O
AV	AV	NN	B-NP	O
graft	graft	NN	I-NP	O
infection	infection	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
MICU	MICU	NN	I-NP	O
transfers	transfer	NNS	I-NP	O
for	for	IN	B-PP	O
sepsis	sepsis	NN	B-NP	O
and	and	CC	O	O
recurrent	recurrent	JJ	B-NP	O
C.	C.	FW	I-NP	O
difficile	difficile	JJ	I-NP	O
infections	infection	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
life-threatening	life-threatening	JJ	B-NP	O
epistaxis	epistaxis	NN	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
doing	do	VBG	I-VP	O
relatively	relatively	RB	B-ADVP	O
well	well	RB	I-ADVP	O
at	at	IN	B-PP	O
rehabilitation	rehabilitation	NN	B-NP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
yeast	yeast	NN	B-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
surveillance	surveillance	NN	I-NP	O
culture	culture	NN	I-NP	O
drawn	draw	VBN	B-VP	O
from	from	IN	B-PP	O
her	her	PRP$	B-NP	O
hemodialysis	hemodialysis	NN	I-NP	O
tunneled	tunnel	VBD	B-VP	O
catheter	catheter	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
asymptomatic	asymptomatic	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
fevers	fever	NNS	I-NP	O
or	or	CC	I-NP	O
chills	chill	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
nausea	nausea	NN	I-NP	O
or	or	CC	I-NP	O
vomiting	vomiting	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
does	do	VBZ	B-VP	O
report	report	VB	I-VP	O
some	some	DT	B-NP	O
lightheadedness	lightheadedness	NN	I-NP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
feels	feel	VBZ	B-VP	O
is	be	VBZ	B-VP	O
her	her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
denies	deny	VBZ	B-VP	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
melena	melena	NN	B-NP	O
,	,	,	O	O
bright	bright	JJ	B-NP	O
red	red	JJ	I-NP	O
blood	blood	NN	I-NP	O
per	per	IN	B-PP	O
rectum	rectum	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
baseline	baseline	NN	B-NP	O
stool	stool	NN	I-NP	O
incontinence	incontinence	NN	I-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
having	have	VBG	I-VP	O
loose	loose	JJ	B-NP	O
stools	stool	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
denies	deny	VBZ	B-VP	O
any	any	DT	B-NP	O
cough	cough	NN	I-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
palpitations	palpitation	NNS	B-NP	O
or	or	CC	O	O
dyspnea	dyspnea	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
states	state	VBZ	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
move	move	VB	I-VP	O
her	her	PRP$	B-NP	O
bilateral	bilateral	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremities	extremity	NNS	I-NP	O
since	since	IN	B-PP	O
her	her	PRP$	B-NP	O
spinal	spinal	JJ	I-NP	O
surgery	surgery	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
notes	note	VBZ	B-VP	O
that	that	IN	B-SBAR	O
her	her	PRP$	B-NP	O
right	right	JJ	I-NP	O
upper	upper	JJ	I-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
resolving	resolve	VBG	I-VP	O
but	but	CC	O	O
began	begin	VBD	B-VP	O
following	follow	VBG	I-VP	O
AV	AV	NN	B-NP	O
graft	graft	NN	I-NP	O
removal	removal	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

End-stage	End-stage	JJ	B-NP	O
renal	renal	JJ	I-NP	O
disease	disease	NN	I-NP	O
on	on	IN	B-PP	O
dialysis	dialysis	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Diabetes	Diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
with	with	IN	B-PP	O
peripheral	peripheral	JJ	B-NP	O
neuropathy	neuropathy	NN	I-NP	O
,	,	,	O	O
nephropathy	nephropathy	NN	B-NP	O
,	,	,	O	O
retinopathy	retinopathy	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Hyperlipidemia	Hyperlipidemia	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

MRSA	MRSA	NN	B-NP	O
osteomyelitis	osteomyelitis	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
spinal	spinal	JJ	I-NP	O
fusion	fusion	NN	I-NP	O
in	in	IN	B-PP	O
8/13	8/13	CD	B-NP	O
for	for	IN	B-PP	O
cord	cord	NN	B-NP	O
compression	compression	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

AV	AV	NN	B-NP	O
graft	graft	NN	I-NP	O
infection	infection	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
removal	removal	NN	I-NP	O
in	in	IN	B-PP	O
8/13	8/13	CD	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Spinal	Spinal	JJ	B-NP	O
stenosis	stenosis	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	NN	I-NP	O
left	leave	VBD	B-VP	O
below-knee	below-knee	JJ	B-NP	O
amputation	amputation	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
osteomyelitis	osteomyelitis	NN	B-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Recurrent	Recurrent	NNP	B-NP	O
C.	C.	NNP	I-NP	O
difficile	difficile	JJ	I-NP	O
infections	infection	NNS	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Paroxysmal	Paroxysmal	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

CVA	CVA	NN	B-NP	O
in	in	IN	B-PP	O
8/13	8/13	CD	B-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Anemia	Anemia	NNP	B-NP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

Depression	Depression	NN	B-NP	O
.	.	.	O	O

14	14	CD	B-NP	O
.	.	.	O	O

Severe	Severe	JJ	B-NP	O
epistaxis	epistaxis	NN	I-NP	O
in	in	IN	B-PP	O
8/13	8/13	CD	B-NP	O
.	.	.	O	O

15	15	CD	B-NP	O
.	.	.	O	O

Recent	Recent	JJ	B-NP	O
diabetic	diabetic	JJ	I-NP	O
ketoacidosis	ketoacidosis	NN	I-NP	O
in	in	IN	B-PP	O
8/13	8/13	CD	B-NP	O
.	.	.	O	O

16	16	CD	B-NP	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
hyponatremia	hyponatremia	NN	B-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
AT	AT	NN	I-NP	O
REHABILITATION	REHABILITATION	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Nephrocaps	Nephrocaps	RB	B-NP	O
one	one	CD	I-NP	O
tab	tab	NN	I-NP	B-protein
once	once	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Lopressor	Lopressor	NN	B-NP	O
37.5	37.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
four	four	CD	B-NP	O
times	time	NNS	I-NP	O
daily	daily	RB	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Lactobacillus	Lactobacillus	NN	B-NP	B-protein
two	two	CD	B-NP	I-protein
tabs	tab	NNS	I-NP	I-protein
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Folic	Folic	JJ	B-NP	O
acid	acid	NN	I-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Nexium	Nexium	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Celexa	Celexa	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Vitamin	Vitamin	NN	B-NP	O
C	C	NN	I-NP	O
250	250	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Amiodarone	Amiodarone	NN	B-NP	O
400	400	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Vancomycin	Vancomycin	NN	B-NP	O
125	125	CD	I-NP	O
mg	mg	NN	I-NP	O
orally	orally	RB	B-NP	O
every	every	DT	I-NP	O
12	12	CD	I-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Neutrophos	Neutrophos	NNP	B-NP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
daily	daily	RB	I-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Levaquin	Levaquin	NN	B-NP	O
250	250	CD	I-NP	O
mg	mg	NN	I-NP	O
every	every	DT	B-NP	O
other	other	JJ	I-NP	O
day	day	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
to	to	TO	B-VP	O
end	end	VB	I-VP	O
4/18/07	4/18/07	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Humalog	Humalog	NN	B-NP	O
4	4	CD	I-NP	O
units	unit	NNS	I-NP	O
q.a.c.	q.a.c.	NN	B-NP	O
13	13	CD	I-NP	O
.	.	.	O	O

NovoLin	NovoLin	IN	B-PP	O
12	12	CD	B-NP	O
units	unit	NNS	I-NP	O
q.a.m.	q.a.m.	NN	B-NP	O
14	14	CD	I-NP	O
.	.	.	O	O

Heparin	Heparin	NN	B-NP	O
5000	5000	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneous	subcutaneous	JJ	B-PP	O
Monday	Monday	NNP	B-NP	O
,	,	,	O	O
Wednesday	Wednesday	NNP	B-NP	O
,	,	,	O	O
Friday	Friday	NNP	B-NP	O
.	.	.	O	O

15	15	CD	B-NP	O
.	.	.	O	O

Reglan	Reglan	NN	B-NP	O
q.a.c.	q.a.c.	NN	I-NP	O
and	and	CC	B-PP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
.	.	.	O	O

16	16	CD	B-NP	O
.	.	.	O	O

Cymbalta	Cymbalta	NN	B-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
17	17	CD	I-NP	O
.	.	.	O	O

Fentanyl	Fentanyl	NN	B-NP	O
patch	patch	NN	I-NP	O
25	25	CD	I-NP	O
mcg	mcg	NN	I-NP	O
q.	q.	NN	I-NP	O
72h	72h	NN	I-NP	O
.	.	.	O	O

18	18	CD	B-NP	O
.	.	.	O	O

Humalog	Humalog	NN	B-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
.	.	.	O	O

19	19	CD	B-NP	O
.	.	.	O	O

Zemplar	Zemplar	JJ	B-NP	O
2	2	CD	I-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	I-NP	O
Monday	Monday	NNP	B-NP	O
,	,	,	O	O
Wednesday	Wednesday	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Friday	Friday	NNP	B-NP	O
.	.	.	O	O

20	20	CD	B-NP	O
.	.	.	O	O

Zinc	Zinc	NN	B-NP	O
220	220	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

21	21	CD	B-NP	O
.	.	.	O	O

Percocet	Percocet	NN	B-NP	O
as	as	IN	B-PP	O
needed	need	VBN	B-VP	O
.	.	.	O	O

22	22	CD	B-NP	O
.	.	.	O	O

Vancomycin	Vancomycin	NN	B-NP	O
1	1	CD	I-NP	O
g	g	NN	I-NP	O
IV	IV	CD	I-NP	O
Monday	Monday	NNP	B-NP	O
,	,	,	O	O
Wednesday	Wednesday	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Friday	Friday	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
to	to	TO	B-VP	O
end	end	VB	I-VP	O
4/18/07	4/18/07	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

23	23	CD	B-NP	O
.	.	.	O	O

Saline	Saline	NN	B-NP	O
nasal	nasal	JJ	I-NP	O
spray	spray	NN	I-NP	O
.	.	.	O	O

24	24	CD	B-NP	O
.	.	.	O	O

Zocor	Zocor	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
denies	deny	VBZ	B-VP	O
any	any	DT	B-NP	O
tobacco	tobacco	NN	I-NP	O
,	,	,	I-NP	O
alcohol	alcohol	NN	I-NP	O
or	or	CC	I-NP	O
illicit	illicit	JJ	I-NP	O
drug	drug	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
lives	live	VBZ	B-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
husband	husband	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
several	several	JJ	B-NP	O
children	child	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
currently	currently	RB	B-ADVP	O
is	be	VBZ	B-VP	O
in	in	IN	B-PP	O
rehabilitation	rehabilitation	NN	B-NP	O
at	at	IN	B-PP	O
Scack-twin	Scack-twin	NNP	B-NP	O
-	-	HYPH	O	O
Pen	Pen	NNP	B-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
.	.	.	O	O

BRIEF	BRIEF	NN	B-NP	O
PHYSICAL	PHYSICAL	NN	I-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
AT	AT	NN	I-NP	O
TIME	TIME	NN	I-NP	O
OF	OF	IN	B-PP	O
ADMISSION	ADMISSION	NN	B-NP	O
:	:	:	O	O
VITAL	VITAL	JJ	B-NP	O
SIGNS	SIGNS	NN	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	B-protein
98.1	98.1	CD	I-NP	I-protein
,	,	,	O	O
pulse	pulse	NN	B-NP	O
78	78	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
128/45	128/45	CD	I-NP	O
,	,	,	O	O
oxygen	oxygen	NN	B-NP	O
saturation	saturation	NN	I-NP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

GENERAL	GENERAL	JJ	B-NP	O
EXAM	EXAM	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
morbidly	morbidly	RB	B-ADVP	O
obesity	obesity	NN	B-NP	O
and	and	CC	O	O
ill-appearing	ill-appearing	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
flat	flat	JJ	I-NP	O
affect	affect	NN	I-NP	O
with	with	IN	B-PP	O
reduced	reduce	VBN	B-NP	O
word-finding	word-finding	NN	I-NP	O
abilities	ability	NNS	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
Pupils	Pupil	NNS	B-NP	O
were	be	VBD	B-VP	O
equal	equal	JJ	B-ADJP	O
,	,	,	I-ADJP	O
round	round	JJ	I-ADJP	O
and	and	CC	I-ADJP	O
reactive	reactive	JJ	I-ADJP	O
.	.	.	O	O

Extraocular	Extraocular	JJ	B-NP	O
movements	movement	NNS	I-NP	O
are	be	VBP	B-VP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

Mucous	Mucous	JJ	B-NP	O
membranes	membrane	NNS	I-NP	O
are	be	VBP	B-VP	O
moist	moist	JJ	B-ADJP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
thrush	thrush	NN	I-NP	O
or	or	CC	I-NP	O
epistaxis	epistaxis	NN	I-NP	O
present	present	JJ	B-ADJP	O
.	.	.	O	O

NECK	NECK	NN	B-NP	O
:	:	:	O	O
Supple	Supple	NNP	B-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
lymphadenopathy	lymphadenopathy	NN	I-NP	O
or	or	CC	O	O
thyromegaly	thyromegaly	RB	B-ADVP	O
.	.	.	O	O

JVP	JVP	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
not	not	RB	I-VP	O
elevated	elevate	VBN	I-VP	O
although	although	IN	B-SBAR	O
was	be	VBD	B-VP	O
difficult	difficult	JJ	B-ADJP	O
to	to	TO	B-VP	O
appreciate	appreciate	VB	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
body	body	NN	B-NP	O
habitus	habitus	NN	I-NP	O
.	.	.	O	O

CARDIOVASCULAR	CARDIOVASCULAR	NN	B-NP	O
:	:	:	O	O
There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
regular	regular	JJ	I-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
S1	S1	NN	I-NP	B-protein
and	and	CC	O	O
S2	S2	NN	B-NP	B-protein
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
holosystolic	holosystolic	JJ	I-NP	O
murmurs	murmur	NNS	I-NP	O
,	,	,	O	O
2/6	2/6	CD	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
apex	apex	NN	I-NP	O
that	that	WDT	B-NP	O
radiates	radiate	VBZ	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
axilla	axilla	NN	I-NP	O
.	.	.	O	O

LUNGS	LUNGS	NN	B-NP	O
:	:	:	O	O
Clear	Clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
on	on	IN	B-PP	O
anterior	anterior	JJ	B-NP	O
exam	exam	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
are	be	VBP	B-VP	O
no	no	DT	B-NP	O
wheezes	wheeze	NNS	I-NP	O
,	,	,	I-NP	O
rhonchi	rhonchus	NNS	I-NP	O
or	or	CC	I-NP	O
rales	rale	NNS	I-NP	O
.	.	.	O	O

ABDOMEN	ABDOMEN	NN	B-NP	O
:	:	:	O	O
Obese	Obese	JJ	B-NP	O
,	,	,	I-NP	O
soft	soft	JJ	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
diffuse	diffuse	JJ	B-NP	O
right-sided	right-sided	JJ	I-NP	O
tenderness	tenderness	NN	I-NP	O
to	to	TO	B-PP	O
palpation	palpation	NN	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
also	also	RB	B-ADVP	O
right	right	JJ	B-NP	O
upper	upper	JJ	I-NP	O
quadrant	quadrant	JJ	I-NP	O
tenderness	tenderness	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
negative	negative	JJ	I-NP	O
Murphy	Murphy	NNP	I-NP	O
's	's	POS	B-NP	O
sign	sign	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
rebound	rebound	NN	I-NP	O
tenderness	tenderness	NN	I-NP	O
or	or	CC	I-NP	O
guarding	guarding	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
are	be	VBP	B-VP	O
distant	distant	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	VBZ	B-VP	O
present	present	JJ	B-ADJP	O
.	.	.	O	O

EXTREMITIES	EXTREMITIES	NNS	B-NP	O
:	:	:	O	O
There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
right	right	JJ	I-NP	O
upper	upper	JJ	I-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
1	1	CD	B-NP	O
+	+	SYM	O	O
pitting	pit	VBG	B-VP	O
edema	edema	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
foot	foot	NN	I-NP	O
.	.	.	O	O

Left	Left	JJ	B-NP	O
leg	leg	NN	I-NP	O
demonstrate	demonstrate	VBP	B-VP	O
a	a	DT	B-NP	O
below-knee	below-knee	JJ	I-NP	O
amputation	amputation	NN	I-NP	O
.	.	.	O	O

NEURO	NEURO	NN	B-NP	B-protein
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
alert	alert	JJ	B-NP	O
and	and	CC	I-NP	O
oriented	orient	VBN	I-NP	O
x3	x3	NN	I-NP	O
.	.	.	O	O

Cranial	Cranial	NNP	B-NP	O
nerves	nerve	VBZ	B-VP	O
II	II	CD	B-NP	O
through	through	IN	B-PP	O
XII	XII	NN	B-NP	B-DNA
are	be	VBP	B-VP	O
grossly	grossly	RB	B-ADJP	O
intact	intact	JJ	I-ADJP	O
.	.	.	O	O

Strength	Strength	NNP	B-NP	O
is	be	VBZ	B-VP	O
4/5	4/5	CD	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
bilateral	bilateral	JJ	I-NP	O
upper	upper	JJ	I-NP	O
extremities	extremity	NNS	I-NP	O
and	and	CC	O	O
3/5	3/5	CD	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
bilateral	bilateral	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremities	extremity	NNS	I-NP	O
.	.	.	O	O

Reflexes	Reflex	NNS	B-NP	O
are	be	VBP	B-VP	O
depressed	depress	VBN	I-VP	O
throughout	throughout	IN	B-PP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
right-sided	right-sided	JJ	I-NP	O
loss	loss	NN	I-NP	O
of	of	IN	B-PP	O
sensation	sensation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
lower	low	JJR	I-NP	O
extremities	extremity	NNS	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
proximal	proximal	JJ	I-NP	O
thigh	thigh	NN	I-NP	O
down	down	IN	B-ADVP	O
and	and	CC	O	O
sensation	sensation	NN	B-NP	O
to	to	TO	B-PP	O
light	light	JJ	B-NP	O
touch	touch	NN	I-NP	O
is	be	VBZ	B-VP	O
intact	intact	JJ	B-ADJP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
.	.	.	O	O

SKIN	SKIN	NN	B-NP	B-protein
:	:	:	O	O
Midthoracic	Midthoracic	JJ	B-NP	O
spine	spine	NN	I-NP	O
is	be	VBZ	B-VP	O
under	under	IN	B-PP	O
dressing	dress	VBG	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
dressing	dressing	NN	I-NP	O
is	be	VBZ	B-VP	O
clean	clean	JJ	B-ADJP	O
,	,	,	I-ADJP	O
dry	dry	JJ	I-ADJP	O
and	and	CC	I-ADJP	O
intact	intact	JJ	I-ADJP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
sacral	sacral	JJ	I-NP	O
decubitus	decubitus	NN	I-NP	O
ulcer	ulcer	NN	I-NP	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
under	under	IN	B-PP	O
dressing	dress	VBG	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
right	right	JJ	B-NP	O
groin	groin	NN	I-NP	O
maceration	maceration	NN	I-NP	O
.	.	.	O	O

PERTINENT	PERTINENT	NN	B-NP	O
LAB	LAB	NN	I-NP	O
VALUES	VALUES	NNS	I-NP	O
:	:	:	O	O
Sodium	Sodium	NN	B-NP	O
131	131	NN	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
5.2	5.2	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
95	95	CD	I-NP	O
,	,	,	O	O
bicarbonate	bicarbonate	NN	B-NP	O
31	31	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
16	16	CD	I-NP	I-DNA
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
2.4	2.4	CD	I-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	O
117	117	CD	I-NP	O
.	.	.	O	O

WBCs	WBC	NNS	B-NP	B-protein
14.4	14.4	CD	B-NP	I-protein
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
36.7	36.7	CD	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
platelets	platelet	NNS	B-NP	B-cell_type
343	343	CD	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
are	be	VBP	B-VP	O
61.5	61.5	CD	B-NP	O
%	%	NN	I-NP	O
neutrophils	neutrophil	NNS	I-NP	B-cell_type
.	.	.	O	O

INR	INR	NN	B-NP	O
1.0	1.0	CD	I-NP	O
,	,	,	O	O
PTT	PTT	NN	B-NP	B-protein
28.9	28.9	CD	I-NP	I-protein
.	.	.	O	O

ALT	ALT	NN	B-NP	B-protein
15	15	CD	I-NP	I-protein
,	,	,	O	O
AST	AST	NN	B-NP	O
46	46	CD	I-NP	O
.	.	.	O	O

Total	Total	JJ	B-NP	O
protein	protein	NN	I-NP	O
6.5	6.5	CD	I-NP	O
,	,	,	O	O
albumin	albumin	NN	B-NP	O
20	20	CD	I-NP	O
.	.	.	O	O

GGT	GGT	NN	B-NP	B-protein
220	220	CD	I-NP	I-protein
.	.	.	O	O

Alkaline	Alkaline	NN	B-NP	O
phosphatase	phosphatase	NN	I-NP	O
513	513	CD	I-NP	O
,	,	,	O	O
total	total	JJ	B-NP	O
bilirubin	bilirubin	NN	I-NP	O
0.7	0.7	CD	I-NP	O
,	,	,	O	O
calcium	calcium	NN	B-NP	O
7.7	7.7	CD	I-NP	O
.	.	.	O	O

DIAGNOSTIC	DIAGNOSTIC	NN	B-NP	O
STUDIES	STUDIES	NNS	I-NP	O
:	:	:	O	O
A	A	DT	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
bilateral	bilateral	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
edema	edema	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
left-sided	left-sided	JJ	I-NP	O
pleural	pleural	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
layered	layered	JJ	I-NP	O
basal	basal	JJ	I-NP	O
right-sided	right-sided	JJ	I-NP	O
pleural	pleural	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
BY	BY	NN	I-NP	O
PROBLEM	PROBLEM	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
59-year-old	59-year-old	JJ	I-NP	O
morbidly	morbidly	RB	I-NP	O
obesity	obesity	NN	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
end-stage	end-stage	JJ	B-NP	O
renal	renal	JJ	I-NP	O
disease	disease	NN	I-NP	O
on	on	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
recent	recent	JJ	I-NP	O
AV	AV	NN	I-NP	O
graft	graft	NN	I-NP	O
infection	infection	NN	I-NP	O
,	,	,	O	O
sepsis	sepsis	NN	B-NP	O
,	,	,	O	O
thoracic	thoracic	JJ	B-NP	O
cord	cord	NN	I-NP	O
compression	compression	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
fusion	fusion	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
MRSA	MRSA	NN	B-NP	O
osteomyelitis	osteomyelitis	NN	I-NP	O
,	,	,	O	O
recurrent	recurrent	JJ	B-NP	O
C.	C.	NNP	I-NP	O
difficile	difficile	JJ	I-NP	O
infections	infection	NNS	I-NP	O
,	,	,	O	O
life-threatening	life-threatening	JJ	B-NP	O
epistaxis	epistaxis	NN	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
embolization	embolization	NN	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
is	be	VBZ	B-VP	O
now	now	RB	I-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Renal	Renal	NNP	I-NP	O
Service	Service	NNP	I-NP	O
with	with	IN	B-PP	O
suspected	suspect	VBN	B-NP	O
fungemia	fungemia	NN	I-NP	O
thought	think	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
tunneled	tunneled	JJ	I-NP	O
catheter	catheter	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
asymptomatic	asymptomatic	JJ	B-ADJP	O
and	and	CC	O	O
hemodynamically	hemodynamically	RB	B-ADJP	O
stable	stable	JJ	I-ADJP	O
.	.	.	O	O

1	1	CD	B-NP	O
.	.	.	O	O
.	.	.	O	O

Infectious	Infectious	JJ	B-NP	O
Disease	Disease	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
positive	positive	JJ	I-NP	O
blood	blood	NN	I-NP	O
culture	culture	NN	I-NP	O
identified	identify	VBN	B-VP	O
on	on	IN	B-PP	O
surveillance	surveillance	NN	B-NP	O
blood	blood	NN	I-NP	O
cultures	culture	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
micafungin	micafungin	NN	B-NP	O
IV	IV	CD	I-NP	O
while	while	IN	B-SBAR	O
speciation	speciation	NN	B-NP	O
and	and	CC	I-NP	O
sensitivities	sensitivity	NNS	I-NP	O
were	be	VBD	B-VP	O
pending	pende	VBG	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
received	receive	VBD	B-VP	O
five	five	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
micafungin	micafungin	NN	B-NP	B-protein
IV	IV	CD	I-NP	I-protein
100	100	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
IV	IV	CD	B-NP	I-protein
daily	daily	RB	I-NP	O
.	.	.	O	O

Cultures	Culture	NNS	B-NP	O
then	then	RB	B-ADVP	O
came	come	VBD	B-VP	O
back	back	RP	B-PRT	O
with	with	IN	B-PP	O
Candida	Candida	NNP	B-NP	O
glabrata	glabrata	NNS	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
sensitive	sensitive	JJ	B-ADJP	O
to	to	TO	B-PP	O
fluconazole	fluconazole	NN	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
converted	convert	VBN	I-VP	O
over	over	RP	B-PRT	O
to	to	TO	B-PP	O
oral	oral	JJ	B-NP	O
fluconazole	fluconazole	NN	I-NP	O
400	400	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

Surveillance	Surveillance	NN	B-NP	O
blood	blood	NN	I-NP	O
cultures	culture	NNS	I-NP	O
with	with	IN	B-PP	O
fungal	fungal	JJ	B-NP	O
isolators	isolator	NNS	I-NP	O
were	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
daily	daily	JJ	I-NP	O
basis	basis	NN	I-NP	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
,	,	,	O	O
all	all	DT	B-NP	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
have	have	VBP	B-VP	O
come	come	VBN	I-VP	O
back	back	RB	B-ADJP	O
negative	negative	JJ	I-ADJP	O
to	to	TO	B-PP	O
date	date	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
her	her	PRP$	B-NP	O
tunneled	tunnel	VBN	I-NP	O
catheter	catheter	NN	I-NP	O
line	line	NN	I-NP	O
pulled	pull	VBD	B-VP	O
on	on	IN	B-PP	O
10/1/07	10/1/07	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
by	by	IN	B-PP	O
Ophthalmology	Ophthalmology	NN	B-NP	O
to	to	TO	B-VP	O
rule	rule	VB	I-VP	O
out	out	RP	B-PRT	O
endophthalmitis	endophthalmitis	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
not	not	RB	O	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
received	receive	VBD	B-VP	O
a	a	DT	B-NP	O
transthoracic	transthoracic	JJ	I-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
to	to	TO	B-VP	O
rule	rule	VB	I-VP	O
out	out	RP	B-PRT	O
vegetation	vegetation	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
MRSA	MRSA	NN	B-NP	O
osteomyelitis	osteomyelitis	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
cord	cord	NN	I-NP	O
compression	compression	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
decompression	decompression	NN	I-NP	O
with	with	IN	B-PP	O
hardware	hardware	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
and	and	CC	O	O
IV	IV	CD	B-NP	O
vancomycin	vancomycin	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
scheduled	schedule	VBN	I-VP	O
to	to	TO	I-VP	O
continue	continue	VB	I-VP	O
until	until	IN	B-PP	O
4/18/07	4/18/07	CD	B-NP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
from	from	IN	B-PP	O
1/25/07	1/25/07	CD	B-NP	O
grew	grow	VBD	B-VP	O
out	out	RP	B-PRT	O
VRE	VRE	NN	B-NP	O
bacteremia	bacteremia	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
converted	convert	VBN	B-VP	O
from	from	IN	B-PP	O
IV	IV	CD	B-NP	O
vancomycin	vancomycin	NN	I-NP	O
to	to	TO	B-VP	O
linezolid	linezolid	VB	I-VP	O
600	600	CD	B-NP	O
mg	mg	NN	I-NP	O
orally	orally	RB	B-ADVP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
on	on	IN	B-PP	O
9/27/07	9/27/07	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
received	receive	VBD	B-VP	O
one	one	CD	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
gentamicin	gentamicin	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
x1	x1	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
new	new	JJ	I-NP	O
tunneled	tunnel	VBN	I-NP	O
catheter	catheter	NN	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
3/7/07	3/7/07	CD	B-NP	O
and	and	CC	O	O
given	give	VBN	B-PP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
blood	blood	NN	I-NP	O
cultures	culture	NNS	I-NP	O
was	be	VBD	B-VP	O
VRE	VRE	NN	B-NP	B-DNA
grew	grow	VBD	B-VP	O
back	back	RB	B-ADJP	O
positive	positive	JJ	I-ADJP	O
on	on	IN	B-PP	O
1/25/07	1/25/07	CD	B-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
certain	certain	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
new	new	JJ	I-NP	O
tunneled	tunnel	VBN	I-NP	O
catheter	catheter	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
the	the	DT	B-NP	O
source	source	NN	I-NP	O
of	of	IN	B-PP	O
VRE	VRE	NN	B-NP	B-DNA
and	and	CC	O	O
the	the	DT	B-NP	O
decision	decision	NN	I-NP	O
was	be	VBD	B-VP	O
made	make	VBN	I-VP	O
to	to	TO	B-VP	O
treat	treat	VB	I-VP	O
through	through	IN	B-PP	O
the	the	DT	B-NP	O
line	line	NN	I-NP	O
.	.	.	O	O

All	All	DT	B-NP	O
subsequent	subsequent	JJ	I-NP	O
blood	blood	NN	I-NP	O
cultures	culture	NNS	I-NP	O
from	from	IN	B-PP	O
9/27/07	9/27/07	CD	B-NP	O
and	and	CC	I-NP	O
2/28/07	2/28/07	CD	I-NP	O
are	be	VBP	B-VP	O
all	all	DT	O	O
negative	negative	JJ	B-ADJP	O
to	to	TO	B-PP	O
date	date	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
one	one	CD	B-NP	O
temperature	temperature	NN	I-NP	O
spike	spike	NN	I-NP	O
to	to	TO	B-PP	O
101	101	CD	B-NP	O
degrees	degree	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
recultured	reculture	VBN	I-VP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
cultures	culture	NNS	I-NP	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
repeat	repeat	NN	I-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
only	only	RB	B-NP	O
minimal	minimal	JJ	I-NP	O
atelectasis	atelectasis	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
pneumonia	pneumonia	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
subsequently	subsequently	RB	B-VP	O
defervesced	defervesce	VBN	I-VP	O
.	.	.	O	O

And	And	CC	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
afebrile	afebrile	RB	B-ADVP	O
for	for	IN	B-PP	O
over	over	IN	B-NP	O
72	72	CD	I-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
,	,	,	O	O
of	of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
C.	C.	NNP	B-NP	O
difficile	difficile	NNP	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
oral	oral	JJ	B-NP	O
vancomycin	vancomycin	NN	I-NP	O
for	for	IN	B-PP	O
suppression	suppression	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
continue	continue	VB	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
numerous	numerous	JJ	B-NP	O
loose	loose	JJ	I-NP	O
stools	stool	NNS	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
and	and	CC	O	O
C.	C.	FW	B-NP	B-cell_line
difficile	difficile	FW	I-NP	I-cell_line
cultures	culture	NNS	I-NP	I-cell_line
were	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
twice	twice	RB	B-ADVP	O
on	on	IN	B-PP	O
6/8/07	6/8/07	CD	B-NP	O
and	and	CC	B-PP	O
again	again	RB	B-ADVP	O
on	on	IN	B-PP	O
3/7/07	3/7/07	CD	B-NP	O
,	,	,	O	O
both	both	DT	B-NP	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
,	,	,	O	O
of	of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
sacral	sacral	JJ	B-NP	O
decubitus	decubitus	NN	I-NP	O
ulcer	ulcer	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
watched	watch	VBN	I-VP	O
closely	closely	RB	B-ADVP	O
for	for	IN	B-PP	O
infection	infection	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
As	As	IN	B-SBAR	O
noted	note	VBN	B-VP	O
above	above	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
tunneled	tunnel	VBN	I-NP	O
catheter	catheter	NN	I-NP	O
was	be	VBD	B-VP	O
removed	remove	VBN	I-VP	O
as	as	IN	B-SBAR	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
deemed	deem	VBN	I-VP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
likely	likely	JJ	I-NP	O
source	source	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
fungemia	fungemia	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
dialyzed	dialyze	VBN	I-VP	O
once	once	RB	B-ADVP	O
through	through	IN	B-PP	O
her	her	PRP	B-NP	B-cell_line
temporary	temporary	JJ	I-NP	I-cell_line
femoral	femoral	JJ	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
and	and	CC	O	O
tunneled	tunnel	VBN	B-NP	O
catheter	catheter	NN	I-NP	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
3/7/07	3/7/07	CD	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
dialyzed	dialyze	VBN	I-VP	O
approximately	approximately	RB	B-NP	O
every	every	DT	I-NP	O
two	two	CD	I-NP	O
days	day	NNS	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
dialysis	dialysis	NN	I-NP	O
on	on	IN	B-PP	O
10/11/07	10/11/07	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
due	due	JJ	B-ADJP	O
for	for	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
on	on	IN	B-PP	O
7/14/07	7/14/07	CD	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Heme	Heme	NN	B-NP	B-protein
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
anemia	anemia	NN	B-NP	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
received	receive	VBD	B-VP	O
1	1	CD	B-NP	O
unit	unit	NN	I-NP	O
of	of	IN	B-PP	O
packed	packed	JJ	B-NP	B-cell_type
red	red	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Gastrointestinal	Gastrointestinal	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
had	have	VBD	B-VP	O
right	right	JJ	B-NP	O
upper	upper	JJ	I-NP	O
quadrant	quadrant	JJ	I-NP	O
tenderness	tenderness	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
elevated	elevated	JJ	I-NP	O
alkaline	alkaline	NN	I-NP	B-protein
phosphatase	phosphatase	NN	I-NP	I-protein
and	and	CC	I-NP	O
GGT	GGT	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
right	right	JJ	I-NP	O
upper	upper	JJ	I-NP	O
quadrant	quadrant	JJ	I-NP	O
ultrasound	ultrasound	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
and	and	CC	O	O
to	to	TO	B-VP	O
rule	rule	VB	I-VP	O
out	out	RP	B-PRT	O
biliary	biliary	JJ	B-NP	O
obstruction	obstruction	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
study	study	NN	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
liver	liver	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
gallbladder	gallbladder	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
few	few	JJ	I-NP	O
small	small	JJ	I-NP	O
stones	stone	NNS	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
sludge	sludge	NN	B-NP	O
,	,	,	O	O
gallbladder	gallbladder	NN	B-NP	O
wall	wall	NN	I-NP	O
thickness	thickness	NN	I-NP	O
was	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
sonographic	sonographic	JJ	I-NP	O
Murphy	Murphy	NNP	I-NP	O
's	's	POS	B-NP	O
sign	sign	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
biliary	biliary	JJ	B-NP	O
tree	tree	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
dilated	dilated	JJ	I-NP	O
common	common	JJ	I-NP	O
bile	bile	NN	I-NP	O
duct	duct	NN	I-NP	O
of	of	IN	B-PP	O
7	7	CD	B-NP	O
mm	mm	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
unchanged	unchanged	JJ	B-NP	O
and	and	CC	I-NP	O
distal	distal	JJ	I-NP	O
ducts	duct	NNS	I-NP	O
were	be	VBD	B-VP	O
not	not	RB	I-VP	O
well	well	RB	I-VP	O
seen	see	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
intrahepatic	intrahepatic	JJ	I-NP	O
ducts	duct	NNS	I-NP	O
were	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
Zocor	Zocor	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
elevated	elevate	VBN	B-NP	O
LFTs	LFT	NNS	I-NP	B-protein
.	.	.	O	O

Abdominal	Abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
resolved	resolve	VBN	B-VP	O
on	on	IN	B-PP	O
hospital	hospital	NN	B-NP	O
day	day	NN	I-NP	O
2	2	CD	B-NP	O
and	and	CC	O	O
LFTs	LFT	NNS	B-NP	B-protein
trended	trend	VBN	B-VP	O
to	to	TO	B-PP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
,	,	,	O	O
of	of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
C.	C.	NNP	B-NP	O
difficile	difficile	JJ	B-ADJP	O
as	as	IN	B-SBAR	O
noted	note	VBN	B-VP	O
above	above	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
diarrhea	diarrhea	NN	B-NP	O
although	although	IN	B-SBAR	O
her	her	PRP$	B-NP	B-cell_line
C.	C.	NNP	I-NP	I-cell_line
difficile	difficile	NN	I-NP	I-cell_line
cultures	culture	NNS	I-NP	I-cell_line
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
symptomatically	symptomatically	RB	B-ADVP	O
with	with	IN	B-PP	O
Lomotil	Lomotil	NNP	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
rectal	rectal	JJ	I-NP	O
tube	tube	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
placed	place	VBN	I-VP	O
given	give	VBN	I-VP	O
her	her	PRP$	B-NP	O
diarrhea	diarrhea	NN	I-NP	O
and	and	CC	O	O
increased	increase	VBN	B-NP	O
pain	pain	NN	I-NP	O
with	with	IN	B-PP	O
soiling	soiling	NN	B-NP	O
of	of	IN	B-PP	O
ulcer	ulcer	NN	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
risk	risk	NN	B-NP	O
of	of	IN	B-PP	O
infection	infection	NN	B-NP	O
.	.	.	O	O

Rectal	Rectal	JJ	B-NP	O
tube	tube	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
continued	continue	VBN	I-VP	O
in	in	IN	B-PP	O
rehab	rehab	NN	B-NP	O
to	to	TO	B-VP	O
prevent	prevent	VB	I-VP	O
infection	infection	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
sacral	sacral	JJ	I-NP	O
ulcers	ulcer	NNS	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
paroxysmal	paroxysmal	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
with	with	IN	B-PP	O
RVR	RVR	NN	B-NP	B-protein
and	and	CC	O	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
Lopressor	Lopressor	NN	I-NP	O
,	,	,	O	O
amiodarone	amiodarone	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
any	any	DT	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
rapid	rapid	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
rate	rate	NN	I-NP	O
,	,	,	O	O
nor	nor	CC	O	O
any	any	DT	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
hemodynamic	hemodynamic	JJ	B-NP	O
instability	instability	NN	I-NP	O
or	or	CC	I-NP	O
hypertension	hypertension	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Neuro	Neuro	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
bilateral	bilateral	JJ	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
weakness	weakness	NN	I-NP	O
and	and	CC	I-NP	O
loss	loss	NN	I-NP	O
of	of	IN	B-PP	O
sensation	sensation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
likely	likely	RB	B-ADVP	O
sequelae	sequela	NNS	B-NP	O
of	of	IN	B-PP	O
recent	recent	JJ	B-NP	O
cord	cord	NN	I-NP	O
compression	compression	NN	I-NP	O
,	,	,	O	O
per	per	IN	B-PP	O
Neuro	Neuro	NNP	B-NP	O
notes	note	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
medical	medical	JJ	I-NP	O
record	record	NN	I-NP	O
from	from	IN	B-PP	O
11/22/06	11/22/06	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
acute	acute	JJ	B-NP	O
delirium	delirium	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-PP	O
a	a	DT	B-NP	O
result	result	NN	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
Reglan	Reglan	NN	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
as	as	IN	B-SBAR	O
was	be	VBD	B-VP	O
her	her	PRP$	B-NP	O
fentanyl	fentanyl	NN	I-NP	O
patch	patch	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
improved	improve	VBD	B-VP	O
although	although	IN	B-SBAR	O
she	she	PRP	B-NP	O
still	still	RB	B-ADVP	O
had	have	VBD	B-VP	O
baseline	baseline	NN	B-NP	O
memory	memory	NN	I-NP	O
deficits	deficit	NNS	I-NP	O
.	.	.	O	O

Psychiatry	Psychiatry	NN	B-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
and	and	CC	O	O
recommended	recommend	VBN	B-VP	O
tapering	taper	VBG	B-VP	O
her	her	PRP$	B-NP	O
Celexa	Celexa	NN	I-NP	O
and	and	CC	I-NP	O
Cymbalta	Cymbalta	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
waxing	wax	VBG	B-VP	O
and	and	CC	I-VP	O
waning	wan	VBG	I-VP	O
mental	mental	JJ	B-NP	O
status	status	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
also	also	RB	I-VP	O
been	be	VBN	I-VP	O
counseled	counsel	VBN	I-VP	O
to	to	TO	B-VP	O
avoid	avoid	VB	I-VP	O
oxycodone	oxycodone	NN	B-NP	O
or	or	CC	O	O
any	any	DT	B-NP	O
other	other	JJ	I-NP	O
narcotics	narcotic	NNS	I-NP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
control	control	NN	I-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
try	try	VB	I-VP	O
to	to	TO	I-VP	O
only	only	RB	I-VP	O
use	use	VB	I-VP	O
Tylenol	Tylenol	NN	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Derm	Derm	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
sacral	sacral	JJ	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
right	right	JJ	B-NP	O
heel	heel	NN	I-NP	O
decubitus	decubitus	NN	I-NP	O
ulcer	ulcer	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
wound	wound	NN	I-NP	O
nurse	nurse	NN	I-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
received	receive	VBD	B-VP	O
Panafil	Panafil	NN	B-NP	O
ointment	ointment	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
sacral	sacral	JJ	I-NP	O
ulcers	ulcer	NNS	I-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

Sacral	Sacral	JJ	B-NP	O
wound	wound	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
irrigated	irrigate	VBN	I-VP	O
with	with	IN	B-PP	O
warm	warm	JJ	B-NP	O
saline	saline	NN	I-NP	O
and	and	CC	O	O
then	then	RB	B-ADVP	O
Panafil	Panafil	NNP	B-NP	O
is	be	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
applied	apply	VBN	I-VP	O
to	to	TO	B-VP	O
open	open	VB	I-VP	O
areas	area	NNS	B-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
and	and	CC	O	O
then	then	RB	B-ADVP	O
wound	wound	NN	B-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
dressed	dress	VBN	I-VP	O
with	with	IN	B-PP	O
dry	dry	JJ	B-NP	O
sterile	sterile	JJ	I-NP	O
dressing	dressing	NN	I-NP	O
,	,	,	O	O
all	all	DT	B-NP	O
twice	twice	RB	I-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
sutures	suture	NNS	B-NP	O
in	in	IN	B-PP	O
place	place	NN	B-NP	O
from	from	IN	B-PP	O
thoracic	thoracic	JJ	B-NP	O
spinal	spinal	JJ	I-NP	O
fusion	fusion	NN	I-NP	O
.	.	.	O	O

Orthopedics	Orthopedic	NNS	B-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
to	to	TO	I-VP	O
remove	remove	VB	I-VP	O
some	some	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
sutures	suture	NNS	I-NP	O
.	.	.	O	O

Approximately	Approximately	RB	B-ADVP	O
,	,	,	O	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
sutures	suture	NNS	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
were	be	VBD	B-VP	O
not	not	RB	O	O
ready	ready	JJ	B-ADJP	O
to	to	TO	B-VP	O
come	come	VB	I-VP	O
out	out	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Hans	Hans	NNP	I-NP	O
V	V	NNP	I-NP	O
Cumoletti	Cumoletti	NNP	I-NP	O
on	on	IN	B-PP	O
1/12/07	1/12/07	CD	B-NP	O
for	for	IN	B-PP	O
removal	removal	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
remaining	remain	VBG	I-NP	O
sutures	suture	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
area	area	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
evaluated	evaluate	VBN	I-VP	O
at	at	IN	B-ADJP	O
least	least	JJS	I-ADJP	O
daily	daily	JJ	I-ADJP	O
and	and	CC	O	O
dressings	dressing	NNS	B-NP	O
changed	change	VBD	B-VP	O
once	once	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
with	with	IN	B-PP	O
dry	dry	JJ	B-NP	O
sterile	sterile	JJ	I-NP	O
dressings	dressing	NNS	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Vascular	Vascular	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
oozing	ooze	VBG	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
site	site	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
old	old	JJ	I-NP	O
AV	AV	NN	I-NP	O
graft	graft	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
antecubital	antecubital	JJ	I-NP	O
fossa	fossa	NN	I-NP	O
on	on	IN	B-PP	O
7/25	7/25	CD	B-NP	O
.	.	.	O	O

Vascular	Vascular	NNP	B-NP	O
Surgery	Surgery	NNP	I-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
and	and	CC	O	O
evacuated	evacuate	VBN	B-VP	O
a	a	DT	B-NP	O
hematoma	hematoma	NN	I-NP	O
on	on	IN	B-PP	O
7/25	7/25	CD	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
wound	wound	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
dressed	dress	VBN	I-VP	O
with	with	IN	B-PP	O
2	2	CD	B-NP	O
x	x	NN	I-NP	O
2s	2	NNS	I-NP	O
,	,	,	O	O
soaked	soak	VBD	B-VP	O
to	to	TO	B-PP	O
normal	normal	JJ	B-NP	O
saline	saline	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
changed	change	VBN	I-VP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
daily	daily	RB	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Daron	Daron	NNP	I-NP	O
T	T	NNP	I-NP	O
Pogar	Pogar	NNP	I-NP	O
from	from	IN	B-PP	O
Vascular	Vascular	NNP	B-NP	O
Surgery	Surgery	NNP	I-NP	O
in	in	IN	B-PP	O
two	two	CD	B-NP	O
weeks	week	NNS	I-NP	O
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
this	this	DT	B-NP	O
wound	wound	JJ	I-NP	B-DNA
site	site	NN	I-NP	I-DNA
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Psychiatry	Psychiatry	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
flat	flat	JJ	I-NP	O
affect	affect	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
appropriately	appropriately	RB	I-VP	O
depressed	depress	VBN	I-VP	O
in	in	IN	B-PP	O
past	past	JJ	B-NP	O
hospitalizations	hospitalization	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
Cymbalta	Cymbalta	NNP	B-NP	O
and	and	CC	I-NP	O
Celexa	Celexa	NNP	I-NP	O
.	.	.	O	O

Psychiatry	Psychiatry	NN	B-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
and	and	CC	O	O
felt	feel	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
demonstrating	demonstrate	VBG	I-VP	O
some	some	DT	B-NP	O
delirium	delirium	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
currently	currently	RB	I-VP	O
not	not	RB	I-VP	O
depressed	depress	VBN	I-VP	O
and	and	CC	O	O
recommended	recommend	VBD	B-VP	O
that	that	DT	O	O
her	her	PRP$	B-NP	O
Cymbalta	Cymbalta	NN	I-NP	O
and	and	CC	I-NP	O
Celexa	Celexa	NN	I-NP	O
be	be	VB	B-VP	O
tapered	taper	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
currently	currently	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
process	process	NN	I-NP	O
of	of	IN	B-PP	O
being	be	VBG	B-VP	O
tapered	taper	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
this	this	DT	B-NP	O
taper	taper	NN	I-NP	O
should	should	MD	B-VP	O
continue	continue	VB	I-VP	O
as	as	IN	B-SBAR	O
noted	note	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
discharge	discharge	NN	I-NP	O
medication	medication	NN	I-NP	O
section	section	NN	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Pain	Pain	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
fentanyl	fentanyl	NN	B-NP	O
and	and	CC	I-NP	O
oxycodone	oxycodone	NN	I-NP	O
per	per	IN	B-PP	O
rehabilitation	rehabilitation	NN	B-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
fentanyl	fentanyl	NN	I-NP	O
patch	patch	NN	I-NP	O
was	be	VBD	B-VP	O
quickly	quickly	RB	I-VP	O
discontinued	discontinue	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
one	one	CD	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
acute	acute	JJ	B-NP	O
delirium	delirium	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
oxycodone	oxycodone	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
required	require	VBD	B-VP	O
approximately	approximately	RB	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
oxycodone	oxycodone	NN	B-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
counseled	counsel	VBN	I-VP	O
to	to	TO	I-VP	O
try	try	VB	I-VP	O
to	to	TO	I-VP	O
wean	wean	VB	I-VP	O
herself	herself	PRP	B-NP	O
off	off	RP	B-PRT	O
of	of	IN	B-PP	O
oxycodone	oxycodone	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
use	use	VB	B-VP	O
only	only	RB	B-NP	O
Tylenol	Tylenol	NN	I-NP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
given	give	VBN	B-VP	O
propensity	propensity	NN	B-NP	O
to	to	TO	B-PP	O
delirium	delirium	NN	B-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
severe	severe	JJ	B-NP	O
epistaxis	epistaxis	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
had	have	VBN	I-VP	O
any	any	DT	B-NP	O
epistaxis	epistaxis	NN	I-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
saline	saline	NN	B-NP	O
nasal	nasal	JJ	I-NP	O
sprays	spray	NNS	I-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Fluids	Fluid	NNS	B-NP	O
,	,	,	O	O
Electrolytes	Electrolyte	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Nutrition	Nutrition	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
Nutrition	Nutrition	NN	B-NP	B-protein
consultants	consultant	NNS	I-NP	I-protein
.	.	.	O	O

Her	Her	PRP$	B-NP	O
zinc	zinc	NN	I-NP	O
and	and	CC	I-NP	O
vitamin	vitamin	NN	I-NP	O
C	C	NN	I-NP	O
were	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
to	to	TO	B-VP	O
avoid	avoid	VB	I-VP	O
copper	copper	NN	B-NP	O
deficiency	deficiency	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Megace	Megace	NNP	B-NP	O
400	400	CD	I-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
liberal	liberal	JJ	I-NP	O
diet	diet	NN	I-NP	O
to	to	TO	B-VP	O
encourage	encourage	VB	I-VP	O
p.o.	p.o.	NN	B-NP	O
intake	intake	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
required	require	VBD	B-VP	O
some	some	DT	B-NP	O
electrolyte	electrolyte	NN	I-NP	O
repletion	repletion	NN	I-NP	O
including	include	VBG	B-PP	O
repletion	repletion	NN	B-NP	O
of	of	IN	B-PP	O
phosphate	phosphate	NN	B-NP	O
and	and	CC	I-NP	O
potassium	potassium	NN	I-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
phosphate	phosphate	NN	B-NP	O
should	should	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
repleted	replete	VBN	I-VP	O
with	with	IN	B-PP	O
Neutrophos	Neutrophos	NN	B-NP	O
but	but	CC	B-PP	O
with	with	IN	B-PP	O
sodium	sodium	NN	B-NP	O
phosphate	phosphate	NN	I-NP	O
for	for	IN	B-PP	O
phosphates	phosphate	NNS	B-NP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
1.5	1.5	CD	I-NP	O
possibly	possibly	RB	I-NP	O
given	give	VBN	I-NP	O
the	the	DT	B-NP	O
potassium	potassium	NN	I-NP	O
load	load	NN	I-NP	O
and	and	CC	I-NP	O
Neutrophos	Neutrophos	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
however	however	RB	B-ADVP	O
patient	patient	NN	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
IV	IV	CD	B-NP	O
acess	acess	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
should	should	MD	B-VP	O
recieve	recieve	VB	I-VP	O
one	one	CD	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
neutraphos	neutrapho	NNS	B-NP	O
1	1	CD	I-NP	O
packet	packet	NN	I-NP	O
x1	x1	NN	I-NP	O
upon	upon	IN	B-PP	O
arrival	arrival	NN	B-NP	O
to	to	TO	B-VP	O
rehab	rehab	VB	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
should	should	MD	B-VP	O
then	then	RB	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
basic	basic	JJ	I-NP	O
metabolic	metabolic	JJ	I-NP	O
panel	panel	NN	I-NP	O
checked	check	VBD	B-VP	O
on	on	IN	B-PP	O
2/12/07	2/12/07	CD	B-NP	O
to	to	TO	B-VP	O
ensure	ensure	VB	I-VP	O
her	her	PRP$	B-NP	O
potassium	potassium	NN	I-NP	O
is	be	VBZ	B-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

Prophylaxis	Prophylaxis	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
subcutaneous	subcutaneous	JJ	B-NP	O
heparin	heparin	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
PPI	PPI	NN	I-NP	B-protein
.	.	.	O	O

CODE	CODE	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
full	full	JJ	I-NP	O
code	code	NN	I-NP	O
.	.	.	O	O

HEALTHCARE	HEALTHCARE	NN	B-NP	O
PROXY	PROXY	NN	I-NP	O
:	:	:	O	O
Mr.	Mr.	NNP	B-NP	O
Zane	Zane	NNP	I-NP	O
Fite	Fite	NNP	I-NP	O
,	,	,	O	O
telephone	telephone	NN	B-NP	O
number	number	NN	I-NP	O
570-564-8873	570-564-8873	CD	I-NP	O
.	.	.	O	O

LAST	LAST	NN	B-NP	O
PERTINENT	PERTINENT	NN	I-NP	O
TESTS	TESTS	VBZ	B-VP	O
AT	AT	NN	B-NP	O
TIME	TIME	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
:	:	:	O	O
Sodium	Sodium	NN	B-NP	O
136	136	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
3.7	3.7	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
104	104	CD	I-NP	O
,	,	,	O	O
bicarbonate	bicarbonate	NN	B-NP	O
22	22	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-protein
9	9	CD	I-NP	I-protein
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
2.2	2.2	CD	I-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	O
116	116	CD	I-NP	O
,	,	,	O	O
magnesium	magnesium	NN	B-NP	O
1.7	1.7	CD	I-NP	O
and	and	CC	O	O
phosphate	phosphate	NN	B-NP	O
1.0	1.0	CD	I-NP	O
.	.	.	O	O

ALT	ALT	NN	B-NP	B-protein
6	6	CD	I-NP	I-protein
,	,	,	O	O
AST	AST	NN	B-NP	O
31	31	CD	I-NP	O
.	.	.	O	O

Alkaline	Alkaline	NN	B-NP	O
phosphatase	phosphatase	NN	I-NP	O
189	189	CD	I-NP	O
,	,	,	O	O
total	total	JJ	B-NP	O
bilirubin	bilirubin	NN	I-NP	O
0.6	0.6	CD	I-NP	O
.	.	.	O	O

White	White	JJ	B-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
11.8	11.8	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
27.6	27.6	CD	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
platelets	platelet	NNS	B-NP	B-cell_type
295	295	CD	B-NP	O
.	.	.	O	O

PT	PT	NN	B-NP	B-protein
1.2	1.2	CD	I-NP	I-protein
and	and	CC	O	O
PTT	PTT	NN	B-NP	B-protein
24.9	24.9	CD	I-NP	I-protein
.	.	.	O	O

KEY	KEY	NN	B-NP	O
FEATURES	FEATURES	NNS	I-NP	O
OF	OF	IN	B-PP	O
PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
AT	AT	IN	B-PP	O
THE	THE	DT	B-NP	O
TIME	TIME	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
:	:	:	O	O
VITAL	VITAL	JJ	B-NP	O
SIGNS	SIGNS	NN	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	B-protein
98.9	98.9	CD	I-NP	I-protein
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
108/60	108/60	CD	I-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
76	76	CD	I-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
20	20	CD	I-NP	O
,	,	,	O	O
oxygen	oxygen	NN	B-NP	O
saturation	saturation	NN	I-NP	O
99-100	99-100	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

GENERAL	GENERAL	NN	B-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
general	general	JJ	B-NP	O
exam	exam	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
flat	flat	JJ	I-NP	O
affect	affect	NN	I-NP	O
with	with	IN	B-PP	O
some	some	DT	B-NP	O
word-finding	word-finding	JJ	I-NP	O
difficulties	difficulty	NNS	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
Pupils	Pupil	NNS	B-NP	O
are	be	VBP	B-VP	O
equal	equal	JJ	B-NP	O
,	,	,	I-NP	O
round	round	JJ	I-NP	O
and	and	CC	I-NP	O
reactive	reactive	JJ	I-NP	O
to	to	TO	B-PP	O
light	light	NN	B-NP	O
and	and	CC	I-NP	O
accommodation	accommodation	NN	I-NP	O
.	.	.	O	O

Extraocular	Extraocular	JJ	B-NP	O
movements	movement	NNS	I-NP	O
were	be	VBD	B-VP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

Sclerae	Sclerae	NNS	B-NP	O
are	be	VBP	B-VP	O
anicteric	anicteric	JJ	B-ADJP	O
.	.	.	O	O

Oropharynx	Oropharynx	NNP	B-NP	O
is	be	VBZ	B-VP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

Mucous	Mucous	JJ	B-NP	O
membranes	membrane	NNS	I-NP	O
are	be	VBP	B-VP	O
somewhat	somewhat	RB	B-ADJP	O
dry	dry	JJ	I-ADJP	O
.	.	.	O	O

PULMONARY	PULMONARY	NN	B-NP	O
:	:	:	O	O
Lungs	Lung	NNS	B-NP	O
are	be	VBP	B-VP	O
clear	clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
anterior	anterior	JJ	I-NP	O
exam	exam	NN	I-NP	O
.	.	.	O	O

CARDIOVASCULAR	CARDIOVASCULAR	NN	B-NP	O
:	:	:	O	O
There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
regular	regular	JJ	I-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
S1	S1	NN	I-NP	B-protein
and	and	CC	O	O
S2	S2	NN	B-NP	B-protein
.	.	.	O	O

A	A	DT	B-NP	O
II/VI	II/VI	NNP	I-NP	O
holosystolic	holosystolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
apex	apex	NN	I-NP	O
with	with	IN	B-PP	O
radiation	radiation	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
axilla	axilla	NN	I-NP	O
.	.	.	O	O

ABDOMEN	ABDOMEN	NN	B-NP	O
:	:	:	O	O
There	There	EX	B-NP	O
are	be	VBP	B-VP	O
positive	positive	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
is	be	VBZ	B-VP	O
obese	obese	JJ	B-NP	O
,	,	,	I-NP	O
soft	soft	JJ	I-NP	O
,	,	,	I-NP	O
nondistended	nondistended	JJ	I-NP	O
and	and	CC	I-NP	O
nontender	nontender	JJ	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
rebound	rebound	NN	I-NP	O
tenderness	tenderness	NN	I-NP	O
or	or	CC	I-NP	O
guarding	guarding	NN	I-NP	O
.	.	.	O	O

EXTREMITIES	EXTREMITIES	NNS	B-NP	O
:	:	:	O	O
There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
trace	trace	NN	B-NP	O
edema	edema	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
shin	shin	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
edema	edema	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
.	.	.	O	O

Both	Both	DT	B-NP	O
extremities	extremity	NNS	I-NP	O
are	be	VBP	B-VP	O
warm	warm	JJ	B-ADJP	O
and	and	CC	O	O
well	well	RB	B-ADJP	O
perfused	perfuse	VBN	I-ADJP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
dorsalis	dorsalis	NN	I-NP	O
pedis	pedis	NN	I-NP	O
pulse	pulse	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
foot	foot	NN	I-NP	O
.	.	.	O	O

NEURO	NEURO	NN	B-NP	O
EXAM	EXAM	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
alert	alert	JJ	B-NP	O
and	and	CC	I-NP	O
oriented	orient	VBN	I-NP	O
x3	x3	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
her	her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
weakness	weakness	NN	I-NP	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
unchanged	unchanged	JJ	B-ADJP	O
from	from	IN	B-PP	O
initial	initial	JJ	B-NP	O
exam	exam	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Tylenol	Tylenol	NN	B-NP	O
650	650	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
4h	4h	NN	I-NP	O
.	.	.	O	O

as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Amiodarone	Amiodarone	NN	B-NP	B-protein
400	400	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
q.a.m.	q.a.m.	NN	I-NP	I-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

Celexa	Celexa	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
daily	daily	JJ	I-NP	O
x1	x1	NN	I-NP	O
dose	dose	NN	I-NP	O
on	on	IN	B-PP	O
7/14/07	7/14/07	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
discontinue	discontinue	VBP	B-VP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Lomotil	Lomotil	IN	B-PP	O
two	two	CD	B-NP	O
tabs	tab	NNS	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
four	four	CD	I-ADVP	O
times	time	NNS	I-ADVP	O
daily	daily	RB	I-ADVP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
diarrhea	diarrhea	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Nexium	Nexium	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Fluconazole	Fluconazole	NN	B-NP	O
400	400	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
until	until	IN	B-PP	O
1/12/07	1/12/07	CD	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Folic	Folic	JJ	B-NP	O
acid	acid	NN	I-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

NovoLog	NovoLog	NN	B-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

NovoLog	NovoLog	NN	B-NP	O
4	4	CD	I-NP	O
units	unit	NNS	I-NP	O
subcutaneous	subcutaneous	JJ	B-NP	O
a.c.	a.c.	NN	I-NP	O
10	10	CD	I-NP	O
.	.	.	O	O

Insulin	Insulin	NN	B-NP	B-protein
NPH	NPH	NN	I-NP	I-protein
8	8	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
subcutaneous	subcutaneous	JJ	B-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
11	11	CD	I-NP	O
.	.	.	O	O

Lactinex	Lactinex	NNP	B-NP	O
granules	granule	VBZ	B-VP	O
two	two	CD	B-NP	O
tabs	tab	NNS	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
daily	daily	RB	I-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Levofloxacin	Levofloxacin	NN	B-NP	B-protein
250	250	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	FW	B-PP	I-protein
every	every	DT	B-NP	I-protein
48	48	CD	I-NP	I-protein
hours	hour	NNS	I-NP	I-protein
,	,	,	O	O
to	to	TO	B-VP	O
continue	continue	VB	I-VP	O
until	until	IN	B-PP	O
4/18/07	4/18/07	CD	B-NP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

Lidoderm	Lidoderm	NN	B-NP	O
patch	patch	NN	I-NP	O
5	5	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
place	place	NN	B-NP	O
one	one	CD	I-NP	O
each	each	DT	B-NP	O
daily	daily	RB	B-ADVP	O
to	to	TO	B-PP	O
buttocks	buttock	NNS	B-NP	O
.	.	.	O	O

14	14	CD	B-NP	O
.	.	.	O	O

Linezolid	Linezolid	NN	B-NP	O
600	600	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
12h	12h	NN	I-NP	O
.	.	.	O	O

for	for	IN	B-PP	O
11	11	CD	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
to	to	TO	B-VP	O
end	end	VB	I-VP	O
1/6/07	1/6/07	CD	B-NP	O
.	.	.	O	O

15	15	CD	B-NP	O
.	.	.	O	O

Maalox	Maalox	NN	B-NP	O
tablets	tablet	NNS	I-NP	O
one	one	CD	B-NP	O
to	to	TO	I-NP	O
two	two	CD	I-NP	O
tabs	tab	NNS	I-NP	O
p.o.	p.o.	FW	B-PP	O
every	every	DT	B-NP	O
six	six	CD	I-NP	O
hour	hour	NN	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
upset	upset	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

16	16	CD	B-NP	O
.	.	.	O	O

Milk	Milk	NN	B-NP	O
of	of	IN	B-PP	O
magnesia	magnesia	NN	B-NP	O
30	30	CD	I-NP	O
mL	mL	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
constipation	constipation	NN	B-NP	O
.	.	.	O	O

17	17	CD	B-NP	O
.	.	.	O	O

Megace	Megace	NN	B-NP	O
400	400	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

18	18	CD	B-NP	O
.	.	.	O	O

Lopressor	Lopressor	NN	B-NP	O
37.5	37.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
four	four	CD	B-NP	O
times	time	NNS	I-NP	O
daily	daily	RB	I-NP	O
.	.	.	O	O

19	19	CD	B-NP	O
.	.	.	O	O

Miconazole	Miconazole	NN	B-NP	O
nitrate	nitrate	NN	I-NP	O
2	2	CD	B-NP	O
%	%	NN	I-NP	O
powder	powder	NN	I-NP	O
topically	topically	RB	B-NP	O
b.i.d.	b.i.d.	RB	I-NP	O
20	20	CD	I-NP	O
.	.	.	O	O

Nephrocaps	Nephrocaps	RB	B-NP	O
one	one	CD	I-NP	O
tab	tab	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

21	21	CD	B-NP	O
.	.	.	O	O

Oxycodone	Oxycodone	NN	B-NP	O
5-10	5-10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
4h	4h	NN	I-NP	O
.	.	.	O	O

as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
.	.	.	O	O

22	22	CD	B-NP	O
.	.	.	O	O

Panafil	Panafil	NN	B-NP	O
ointment	ointment	NN	I-NP	O
topically	topically	RB	B-ADVP	O
to	to	TO	B-VP	O
open	open	VB	I-VP	O
areas	area	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
sacral	sacral	JJ	I-NP	O
ulcer	ulcer	NN	I-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

23	23	CD	B-NP	O
.	.	.	O	O

Seroquel	Seroquel	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
agitation	agitation	NN	B-NP	O
.	.	.	O	O

24	24	CD	B-NP	O
.	.	.	O	O

Saline	Saline	NN	B-NP	O
nasal	nasal	JJ	I-NP	O
drops	drop	VBZ	B-VP	O
two	two	CD	B-NP	O
sprays	spray	NNS	I-NP	O
in	in	IN	B-PP	O
each	each	DT	B-NP	O
nares	nare	NNS	I-NP	O
four	four	CD	B-NP	O
times	time	NNS	I-NP	O
daily	daily	RB	I-NP	O
.	.	.	O	O

25	25	CD	B-NP	O
.	.	.	O	O

Trazodone	Trazodone	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
insomnia	insomnia	NN	I-NP	O
.	.	.	O	O

26	26	CD	B-NP	O
.	.	.	O	O

Xenaderm	Xenaderm	NN	B-NP	O
topically	topically	RB	I-NP	O
TP	TP	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
27	27	CD	I-NP	O
.	.	.	O	O

Vancomycin	Vancomycin	NN	B-NP	O
125	125	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
12h	12h	NN	I-NP	O
.	.	.	O	O

,	,	,	O	O
to	to	TO	B-VP	O
continue	continue	VB	I-VP	O
five	five	CD	B-NP	O
days	day	NNS	I-NP	O
until	until	IN	B-PP	O
all	all	DT	B-NP	O
other	other	JJ	I-NP	O
antibiotics	antibiotic	NNS	I-NP	O
are	be	VBP	B-VP	O
discontinued	discontinue	VBN	I-VP	O
.	.	.	O	O

28	28	CD	B-NP	O
.	.	.	O	O

Cymbalta	Cymbalta	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
for	for	IN	B-PP	O
one	one	CD	B-NP	O
dose	dose	NN	I-NP	O
on	on	IN	B-PP	O
1/23/07	1/23/07	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
Cymbalta	Cymbalta	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
for	for	IN	B-PP	O
one	one	CD	B-NP	O
dose	dose	NN	I-NP	O
on	on	IN	B-PP	O
7/11/07	7/11/07	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
discontinue	discontinue	VB	B-VP	O
Cymbalta	Cymbalta	NNP	B-NP	O
.	.	.	O	O

29	29	CD	B-NP	O
.	.	.	O	O

Zemplar	Zemplar	JJ	B-NP	O
2	2	CD	I-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	I-NP	O
Monday	Monday	NNP	B-NP	O
,	,	,	O	O
Wednesday	Wednesday	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Friday	Friday	NNP	B-NP	O
.	.	.	O	O

30	30	CD	B-NP	O
.	.	.	O	O

Heparin	Heparin	NN	B-NP	O
5000	5000	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneous	subcutaneous	JJ	B-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
31	31	CD	I-NP	O
.	.	.	O	O

Neutraphos	Neutrapho	NNS	B-NP	O
1	1	CD	I-NP	O
packet	packet	NN	I-NP	O
PO	PO	NN	I-NP	O
x1	x1	NN	I-NP	O
upon	upon	IN	B-PP	O
arrival	arrival	NN	B-NP	O
to	to	TO	B-VP	O
rehab	rehab	VB	I-VP	O
DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
rehabilitation	rehabilitation	NN	B-NP	O
.	.	.	O	O

PENDING	PENDING	VBG	B-VP	O
TESTS	TESTS	NNS	B-NP	O
:	:	:	O	O
At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
multiple	multiple	JJ	B-NP	O
blood	blood	NN	I-NP	O
cultures	culture	NNS	I-NP	O
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
pending	pende	VBG	I-VP	O
that	that	DT	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
up	up	RP	B-PRT	O
by	by	IN	B-PP	O
physicians	physician	NNS	B-NP	O
at	at	IN	B-PP	O
her	her	PRP$	B-NP	O
rehabilitation	rehabilitation	NN	I-NP	O
.	.	.	O	O

FOLLOW-UP	FOLLOW-UP	NN	B-NP	O
PLANS	PLANS	NNS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
note	note	VBP	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
due	due	JJ	B-ADJP	O
for	for	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
on	on	IN	B-PP	O
7/14/07	7/14/07	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
go	go	VB	I-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
scheduled	scheduled	JJ	I-NP	O
follow-up	follow-up	NN	I-NP	O
appointment	appointment	NN	I-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Van	Van	NNP	I-NP	O
Krapf	Krapf	NNP	I-NP	O
of	of	IN	B-PP	O
Infectious	Infectious	JJ	B-NP	O
Disease	Disease	NN	I-NP	O
on	on	IN	B-PP	O
1/30/07	1/30/07	CD	B-NP	O
at	at	IN	B-PP	O
10	10	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
a.m.	a.m.	RB	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
should	should	MD	B-VP	O
also	also	RB	I-VP	O
go	go	VB	I-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
follow-up	follow-up	JJ	I-NP	O
appointment	appointment	NN	I-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Arden	Arden	NNP	I-NP	O
D	D	NNP	I-NP	O
Iwata	Iwata	NNP	I-NP	O
from	from	IN	B-PP	O
Orthopedics	Orthopedics	NNP	B-NP	O
on	on	IN	B-PP	O
1/12/07	1/12/07	CD	B-NP	O
at	at	IN	B-PP	O
9	9	CD	B-NP	O
:	:	:	O	O
45	45	CD	B-NP	O
a.m.	a.m.	NN	I-NP	O
for	for	IN	B-PP	O
evaluation	evaluation	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
sutures	suture	NNS	I-NP	O
and	and	CC	O	O
possible	possible	JJ	B-NP	O
removal	removal	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
also	also	RB	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Leif	Leif	NNP	I-NP	O
Deatley	Deatley	NNP	I-NP	O
from	from	IN	B-PP	O
Vascular	Vascular	NNP	B-NP	O
Surgery	Surgery	NNP	I-NP	O
in	in	IN	B-PP	O
two	two	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
should	should	MD	B-VP	O
call	call	VB	I-VP	O
the	the	DT	B-NP	O
office	office	NN	I-NP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
telephone	telephone	NN	I-NP	O
number	number	NN	I-NP	O
is	be	VBZ	B-VP	O
178-843-9703	178-843-9703	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
full	full	JJ	I-NP	O
code	code	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
healthcare	healthcare	NN	I-NP	O
proxy	proxy	NN	I-NP	O
is	be	VBZ	B-VP	O
Mr.	Mr.	NNP	B-NP	O
Justin	Justin	NNP	I-NP	O
G	G	NNP	I-NP	O
Revay	Revay	NNP	I-NP	O
,	,	,	O	O
telephone	telephone	NN	B-NP	O
number	number	NN	I-NP	O
570-564-8873	570-564-8873	CD	I-NP	O
.	.	.	O	O

PRIMARY	PRIMARY	NN	B-NP	O
CARE	CARE	NN	I-NP	O
PHYSICIAN	PHYSICIAN	NN	I-NP	O
:	:	:	O	O
Stan	Stan	NNP	B-NP	O
Okel	Okel	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
eScription	eScription	NN	I-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
5-9514833	5-9514833	CD	B-NP	O
EMSSten	EMSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
CC	CC	NNP	I-NP	O
:	:	:	O	O
Denver	Denver	NNP	B-NP	O
Coffey	Coffey	NNP	I-NP	O
M.D.	M.D.	NNP	I-NP	O
BROOMAN	BROOMAN	NNP	I-NP	O
HOSPITAL	HOSPITAL	NNP	I-NP	O
CC	CC	NNP	I-NP	O
:	:	:	O	O
Ricardo	Ricardo	NNP	B-NP	O
Bridgett	Bridgett	NNP	I-NP	O
M.D.	M.D.	NNP	I-NP	O
Gapetha	Gapetha	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
Wark	Wark	NNP	I-NP	O
Montte	Montte	NNP	I-NP	O
CC	CC	NNP	I-NP	O
:	:	:	O	O
Max	Max	NNP	B-NP	O
Acebo	Acebo	NNP	I-NP	O
MD	MD	NNP	I-NP	O
SHA	SHA	NNP	I-NP	O
HEALTHCARE	HEALTHCARE	NNP	I-NP	O
Dura	Dura	NNP	I-NP	O
Re	Re	NNP	I-NP	O
,	,	,	O	O
DIVISION	DIVISION	NNP	B-NP	O
OF	OF	IN	B-PP	O
VASCULAR	VASCULAR	NNP	B-NP	O
SURGERY	SURGERY	NNP	I-NP	O
Lenenas	Lenenas	NNP	I-NP	O
In	In	IN	B-PP	O
Pring	Pring	NNP	B-NP	O
CC	CC	NNP	I-NP	O
:	:	:	O	O
Aurelio	Aurelio	NNP	B-NP	O
Geis	Geis	NNP	I-NP	O
M.D.	M.D.	NNP	I-NP	O
Blo	Blo	NNP	I-NP	O
Saintsrami	Saintsrami	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
.	.	.	O	O

Pavirg	Pavirg	NNP	B-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
BATTISTONI	BATTISTONI	NN	B-NP	O
,	,	,	O	O
ELVIS	ELVIS	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
SCHABOT	SCHABOT	NN	B-NP	O
,	,	,	O	O
JERMAINE	JERMAINE	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
8859264	8859264	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
10/25/07	10/25/07	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
10/25/07	10/25/07	CD	B-NP	O

